NEWS AND EVENTS

Breakfast Meetings

Monthly breakfast meetings are hosted on our Teams channel, and recordings of previous meetings are also available. Log in here.

Not a member? Request membership by contacting us.

Madeleine Doutney

Jun 30, 20222 min read

NAXIVA findings published in British Journal of Cancer

Findings from NAXIVA, the first clinical trial to evaluate neo-adjuvant downstaging of patients with the unique biological phenomenon of...

Madeleine Doutney

Jun 9, 20223 min read

Research reveals how genetic mutations cause kidney cancer

A study has identified how common genetic alterations lead to the development of kidney cancer. Researchers from the University of...

Madeleine Doutney

May 26, 20221 min read

Dr Sarah Welsh and Mr Tom Mitchell talk translational research in ICM Podcast

Dr Sarah Welsh and Mr Tom Mitchell talk about their translational research and how it has helped to determine cancer genetics in renal...

Madeleine Doutney

May 11, 20221 min read

Watch Grant Stewart's John Fitzpatrick Award Lecture at IKCS:Europe

Professor Grant Stewart was awarded the John Fitzpatrick Award by the Kidney Cancer Association at IKCS: Europe 2022 in Antwerp, Belgium...

Madeleine Doutney

Mar 29, 20221 min read

YCR release video detailing YKST's successes

Yorkshire Cancer Research have released a video which details the outstanding progress that the Yorkshire Kidney Screening Trial has made...

Carley Batley

May 6, 20213 min read

'DNA Repair in Urological Malignancies' - a breakfast meeting with Robert Hanson

Robert Hanson, a PhD student in Charlie Massey's lab is studying prostate cancer and developing markers of response and resistance to DNA...

Carley Batley

Feb 24, 20212 min read

Cambridge-led kidney cancer screening trial to start in Leeds

A new study, led by researchers at the University of Cambridge, will investigate the feasibility of developing a full kidney cancer screenin

Dr. Christopher Smith

Oct 14, 20203 min read

Urological Malignancies Programme award moves biomarker research forward

"Mitochondrial ctDNA could add considerably to number of targets available for ctDNA-based assays."